Lipodissolve for subcutaneous fat reduction and skin retraction

Aesthetic Surgery Journal

Volumn 25, Issue 5, 2005, Pages 530-543

  Duncan, Diane Irvine ^a   Hasengschwandtner, Franz ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL ALCOHOL; DEOXYCHOLATE SODIUM; ESSENTIALE; LIPOSTABIL; LIPOSTABIL FORTE; PHOSPHATIDYLCHOLINE;

ARTICLE; BLISTER; BURNING SENSATION; CELLULITIS; CLINICAL TRIAL; CYTOLYSIS; DIARRHEA; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG MARKETING; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; ERYTHEMA; ESTHETIC SURGERY; FACE EDEMA; FAT EMBOLISM; FAT NECROSIS; HUMAN; INJECTION SITE; LIPID STORAGE; LIPODISSOLVE; LIPOSUCTION; MINIMALLY INVASIVE SURGERY; NAUSEA; NONHUMAN; OUTCOMES RESEARCH; PAIN; PARESTHESIA; PATIENT SELECTION; PRIORITY JOURNAL; PRURITUS; SKIN BRUISING; SKIN DEFECT; SKIN INFLAMMATION; SUBCUTANEOUS FAT; TISSUE NECROSIS; VASCULITIS;

EID: 27644491643     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/j.asj.2005.07.009     Document Type: Article

References (58)

1. Bobkova VI Lokshina LI Korsunskii VN et al. Metabolic effect of lipostabil-forte Kardiologiia 29 1989 57-60
2. Jenkins PJ Portmann HP Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: Results of prospective double-blind controlled trial Liver 2 1982 77-81
3. Matarasso A Pfeifer TM Plastic Surgery Educational Foundation DATA Committee Mesotherapy for body contouring Plast Reconstr Surg 115 2005 1420-1424
4. Rohrich R Mesotherapy: What is it? Does it work? Plast Reconstr Surg 115 2005 1425
5. McNamara D Mesotherapy gaining ground as a surgery-free fat reducer Skin and Allergy News 36 2005 1-2
6. Colbert A Manyione H Lipoplasty (liposuction) without surgery update. ASAPS update April 16, 2005 Available at: http://surgery.org/press/news-release.php?iid=370 Accessed June 19, 2005.
7. Muscle Talk Bodybuiding Forum Bought Lipostabil/lipodissolve injections Available at: http://muscletalk.co.uk Accessed May 31, 2005.
8. Lipodissolve and phosphatidylcholine Available at: http://www.buylipodissolve.com Accessed May 31, 2005.
9. Sahelian R Phosphatidylcholine Available at: http://www.raysahelian.com/phospha.html Accessed May 31, 2005.
10. Hasengschwandtner F. Dosages and techniques. Presented at the 1st International Lipolysis Convention; 2005 June 18-19, Salzburg, Austria.
11. Rotunda A Suzuki H Moy R et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution Dermatol Surg 30 2004 1001-1008
12. Phosphatidylcholine: MechaniHm of action Available at: http://www.pdrhealth.comdrug_info/nmdrugprofiles/nutsupdrugs/ pho_02_0288.shtm Accessed May 8, 2005.
13. Spectrum Laboratory. Spectrum material safety data sheet: phosphatidylcholine. Gardena (CA): Spectrum Laboratory Products, Inc. p. 1-6.
14. Hasengschwandtner F. Lipodissolve 2005. Presented at the ASAL/ENLD seminar; 2005 June 11, London, England.
15. Cosmetic Surgery Consultants: Fat reducing injections Available at: http://www.cosmeticsurgeryconsultants.co.uk Accessed May 31, 2005.
16. Grubmeyer H. Optimal treatment regions for PHC. Presented at the 1st International Convention for Lipodissolve; 2005 June 18-19, Salzburg, Austria.
17. Popp G, Hernuss P, et al. Lipodissolve injections in follow-up for correctional treatment after lipoplasty. World Congress on Liposuction Surgery, 2004 Oct 1-3, St. Louis, Missouri.
18. Cimpan MR Matre R Lie SA et al. The coinitiator DMABEE induces death by apoptosis and necrosis in human monoblastoid cells Clin Oral Investig 2005 May 4 [Epub ahead of print].
19. Rose reference.
20. Ablon G Rotunda AM Treatment of lower eyelid fat pads using phosphatidylcholine: Clinical trial and review Dermatol Surg 30 2004 422-427
21. Hasengschwandtner F Austrian Society of Lipodissolve Newsletter January 17, 2005
22. Vickbjerg AF Mu H. Xu X Lipase-catalyzed exchange of soybean phosphatidylcholine in n-Hexane: A critical evaluation of both acyl incorporation and product recovery Biotecnol Prog 21 2005 397-404
23. Lichtenberg D Robson RJ Dennis EA Solubilization of phospholipids by detergents: Structural and kinetic aspects Biochem Biophys Acta 737 1983 285-304
24. Hasengschwandtner F. Injection lipolysis. 1st International Convention for Lipodissolve, 2005 June 18-19, Salzburg, Austria.
25. Mathur S Born E Murthy S et al. Phosphatidylcholine increases the secretion of triacylglycerol-rich lipoproteins by CaCo-2 cells Biochem J 314 1996 569-575
26. Yamamoto M Morita SY Kumon M et al. Effects of plasma apolipoproteins on lipoprotein lipase: Mediated lipolysis of small and large emulsions Biochim Biophys Acta 1632 2003 31-39
27. Gauster M Rechberger G Sovic A et al. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine J Lipid Res 46 2005 1517-1525
28. Ali YB Carriere F Verger R et al. Continuous monitoring of cholesterol oleate hydrolysis by hormone-sensitive lipase and other cholesterol esterases J Lipid Res 46 2005 994-1000
29. Franco M Castro G Romero L et al. Decreased ability of lecithin: cholesterol acyltransferase and hepatic lipase in chronic hypothyroid rats: Implications for reverse cholesterol transport Mol Cell Biochem 246 2003 51-56
30. Ng DS Xie C Maguire GF et al. Hypertriglyc-eridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance J Biol Chem 279 2004 7636-7642
31. Morgan CP Insall R Haynes L Cockcroft S Identification of phospholipidase B from Dictyolstelium discoideum reveals a new lipase family present in mammals Biochem J 2004 441-449
32. Caiazza D Jahangiri A Rader DJ et al. Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high density lipoproteins Biochemistry 43 2004 11898-11905
33. Peckitt N. The molecular biology of adipocyte differentiation and apoptosis. Presented at the 1st International Convention for Lipodissolve; 2005 June 18-19, Salzburg, Austria.
34. van der Lugt CIM. Injection lipolysis and physicotherapy. Presented at the 1st International Lipolysis Convention; 2005 June 18-19, Salzburg, Austria.
35. Ascher B. Optimal dosing of botulinum toxin. IMCAS Cosmetic Botulinum Master Course; 2005 May 28-29, Paris, France.
36. Norek Wojcech. Private study May 2005. E mail: Infonorek.
37. Chapter 18: Phospholipid metabolHsm Available at: http://www.med.uiuc.edu/m1/biochemistry/TA%20reviews/sam/ phospholipids.htm Accessed August 19, 2005.
38. PDR health: PhosphatidylcholHne Available at: http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/ pho_02_0288.shtml Accessed August 19, 2005.
39. Little A Levy R Chua-Kidd P et al. A double-blind, placebo controlled trial of high dose lecithin in Alzheimer's disease J Neurol Neurosurg Psychiatr 48 1985 736-742
40. Cohen BM Lipinski JF Altesman RI Lecithin in the treatment of mania: double blind, placebo controlled trials Am J Psychiatry 139 1982 1162-1164
41. Minas A Online medical consultation Available at: http://www.consultdrminas.com/eng/06_pharmacy/essent_00.php Accessed August 19, 2005.
42. Hasegschwandtner F. Treatment with phosphatidylcholine with special reference to Lipodissolve for localized fat dissolve injections. Presented at Lipodissolve Seminar; 2004 Oct 30, New York.
43. Almazov VA Freidlin IS Krasil'nikova EI Use of lipostabil to correct lipid metabolism disorder with ischemic heart disease Kardiologiia 26 1986 39-42
44. Melchinskaya EN Gromnatasky NI Kirichenko LL Hypolipidemic effects of Alisat and Lipostabil in patients with diabetes mellitus Ter Arkh 72 2000 57-58
45. Lijnen P Echevaria-Vazquez D Petrov V Influence of cholesterol-lowering on plasma membrane lipids and function Methods Find Exp Clin Pharmacol 18 1996 123-136
46. Toouli J Jablonski P Watts JM Gallstone dissolution in man using cholic acid and lecithin Lancet 2 1975 1124-1126
47. Kidd PM Phosphatidylcholine, a superior protectant against liver damage Altern Med Rev 1 1996 258-274
48. Lata J Dastych M Jr Senkyrik M et al. Protective effect of essential phospholipids on liver injury and total parenteral nutrition Vnitr Lek 17 2001 830-834
49. Parnham MJ, Wendel A. Phospholipids and liposomes-safety for cosmetic and pharmaceutical use. Natterman Phospholipid GMBH Scientific Publication #1995432003, 2. Cologne, West Germany: Natterman International GMBH.
50. Coccheri S Alessandri M De Rosa V Platelets and contact activation of blood clotting. Influence of some aggregation inhibitors Acta Med Scandia Suppl 525 1971 253-256
51. Lieber CS Robins SJ Li J et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon Gastroenterology 106 1994 152-159
52. Karkkainenen A Research groups and ongoing studies. ASAL newsletter February 9, 2005 Available at: http://www.asalmember.com Accessed May 31, 2005.
53. Heinrich KG. Efficacy of injections of phosphatidylcholine into fat deposits. Presented at Operative Dermatology Convention; 2004 October 28-31, Frankfurt, Germany.
54. Hexsel D Serra M Mazzuco R et al. Phosphatidylcholine in the treatment of localized fat J Drugs Dermatol 2 2003 511-518
55. Lipoflow forte Available at: http://www.springboard4health.com/store/ more_lipoflow.html Accessed July 5, 2005.
56. Brazil issues notice on lipostabil. RAPS notice April 2005 Available at: http://www.raps.org/s_raps/sec_RANews_Detail.asp Accessed July 19, 2005.
57. Meissner C. Complications with lipodissolve. 1st International Con-vention for Lipodissolve, 2005 June 18-19, Salzburg, Austria.
58. Fat-melting fad: Too good to be true? ASAPS news release November 5, 2004 1-2